(VIANEWS) – Ternium S.A. Ternium S.A. (TX), West Pharmaceutical (WST), NXP Semiconductors (NXPI) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Ternium S.A. Ternium S.A. (TX)

64.1% sales growth and 30.84% return on equity

Ternium S.A., through its subsidiaries, manufactures and processes various steel products in Mexico, Argentina, Paraguay, Chile, Bolivia, Uruguay, Brazil, the United States, Colombia, Guatemala, Costa Rica, Honduras, El Salvador, and Nicaragua.

Ternium S.A. Ternium S.A.’s sales growth this year is anticipated to be 81.1% and a negative 8.5% for next year.

Year-on-year quarterly revenue growth grew by 124.5%, now sitting on 11.89B for the twelve trailing months.

Volume

Today’s last reported volume for Ternium S.A. Ternium S.A. is 461930 which is 39.1% below its average volume of 758540.

Ternium S.A. Ternium S.A.’s sales growth for the next quarter is 64.1%. The company’s growth estimates for the present quarter and the next is 594.6% and 123.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.84%.

Volatility

Ternium S.A. Ternium S.A.’s last day, last week, and last month’s current volatility was 4.05%, 2.28%, and 2.89%, respectively.

Ternium S.A. Ternium S.A.’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.93% (day), 3.12% (last week), and 3.15% (last month), respectively.

Ternium S.A. Ternium S.A.’s Stock Yearly Top and Bottom Value

Ternium S.A. Ternium S.A.’s stock is valued at $46.03 at 16:22 EST, way under its 52-week high of $56.86 and way higher than its 52-week low of $18.51.

Ternium S.A. Ternium S.A.’s Moving Average

Ternium S.A. Ternium S.A.’s worth is higher than its 50-day moving average of $45.69 and higher than its 200-day moving average of $43.62.

2. West Pharmaceutical (WST)

21.2% sales growth and 28.54% return on equity

West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, Ireland, France, Other European countries, and internationally.

West Pharmaceutical’s sales growth this year is anticipated to be 30.4% and 8% for next year.

Year-on-year quarterly revenue growth grew by 37.3%, now sitting on 2.52B for the twelve trailing months.

Volume

Today’s last reported volume for West Pharmaceutical is 298921 which is 8.72% below its average volume of 327510.

West Pharmaceutical’s sales growth for the next quarter is 21.2%. The company’s growth estimates for the present quarter and the next is 56.5% and 41.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.54%.

Volatility

West Pharmaceutical’s last day, last week, and last month’s current volatility was 0.90%, 1.18%, and 1.70%, respectively.

West Pharmaceutical’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.79% (day), 2.19% (last week), and 2.45% (last month), respectively.

West Pharmaceutical’s Stock Yearly Top and Bottom Value

West Pharmaceutical’s stock is valued at $420.30 at 16:22 EST, way under its 52-week high of $475.35 and way above its 52-week low of $253.86.

West Pharmaceutical’s Moving Average

West Pharmaceutical’s worth is below its 50-day moving average of $431.00 and above its 200-day moving average of $383.83.

3. NXP Semiconductors (NXPI)

16.1% sales growth and 12.82% return on equity

NXP Semiconductors N.V. offers various semiconductor products.

NXP Semiconductors’s sales growth this year is anticipated to be 26.8% and 7.3% for next year.

Year-on-year quarterly revenue growth grew by 42.9%, now sitting on 9.94B for the twelve trailing months.

Volume

Today’s last reported volume for NXP Semiconductors is 2538600 which is 26.72% above its average volume of 2003230.

NXP Semiconductors’s sales growth for the next quarter is 16.1%. The company’s growth estimates for the ongoing quarter and the next is 68.5% and 27.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.82%.

Volatility

NXP Semiconductors’s last day, last week, and last month’s current volatility was 0.18%, 1.09%, and 1.92%, respectively.

NXP Semiconductors’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.18% (day), 2.26% (last week), and 2.52% (last month), respectively.

NXP Semiconductors’s Stock Yearly Top and Bottom Value

NXP Semiconductors’s stock is valued at $196.15 at 16:22 EST, way below its 52-week high of $228.72 and way higher than its 52-week low of $126.80.

NXP Semiconductors’s Moving Average

NXP Semiconductors’s value is under its 50-day moving average of $201.28 and under its 200-day moving average of $202.34.

4. Forrester Research (FORR)

8.9% sales growth and 5.85% return on equity

Forrester Research, Inc. operates as an independent research and advisory services company in the United States and internationally.

Forrester Research’s sales growth this year is anticipated to be 9.1% and 8.4% for next year.

Year-on-year quarterly revenue growth grew by 13.3%, now sitting on 471.55M for the twelve trailing months.

Volume

Today’s last reported volume for Forrester Research is 28873 which is 49.54% below its average volume of 57221.

Forrester Research’s sales growth is a negative 0% for the ongoing quarter and 8.9% for the next. The company’s growth estimates for the ongoing quarter and the next is 4.2% and 28.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.85%.

Volatility

Forrester Research’s last day, last week, and last month’s current volatility was 1.27%, 0.85%, and 1.10%, respectively.

Forrester Research’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.35% (day), 2.08% (last week), and 2.50% (last month), respectively.

Forrester Research’s Stock Yearly Top and Bottom Value

Forrester Research’s stock is valued at $52.27 at 16:22 EST, under its 52-week high of $52.89 and way higher than its 52-week low of $35.33.

Forrester Research’s Moving Average

Forrester Research’s worth is higher than its 50-day moving average of $49.42 and way above its 200-day moving average of $45.79.

5. Hanover Insurance Group (THG)

7.7% sales growth and 16.31% return on equity

The Hanover Insurance Group, Inc., through its subsidiaries, provides various property and casualty insurance products and services in the United States.

Hanover Insurance Group’s sales growth this year is expected to be 8% and 5.4% for next year.

Year-on-year quarterly revenue growth grew by 5.6%, now sitting on 5.12B for the twelve trailing months.

Volume

Today’s last reported volume for Hanover Insurance Group is 125765 which is 7.96% below its average volume of 136643.

Hanover Insurance Group’s sales growth for the next quarter is 7.7%. The company’s growth estimates for the present quarter and the next is a negative 62.6% and negative -13.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.31%.

Volatility

Hanover Insurance Group’s last day, last week, and last month’s current volatility was 0.20%, 0.33%, and 0.80%, respectively.

Hanover Insurance Group’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.39% (day), 1.61% (last week), and 1.95% (last month), respectively.

Hanover Insurance Group’s Stock Yearly Top and Bottom Value

Hanover Insurance Group’s stock is valued at $132.03 at 16:22 EST, under its 52-week high of $143.20 and way higher than its 52-week low of $93.17.

Hanover Insurance Group’s Moving Average

Hanover Insurance Group’s value is under its 50-day moving average of $133.27 and under its 200-day moving average of $136.44.

LEAVE A REPLY

Please enter your comment!
Please enter your name here